Tuesday, September 26, 2023
HomeIndustriesJubilant Generics Ltd to invest Rs 864 crore in API capacity expansion

Jubilant Generics Ltd to invest Rs 864 crore in API capacity expansion

- Advertisement -

Capacity expansion at their Nanjangud facility

Jubilant Generics Ltd, a subsidiary of jubilant pharma which specialises in manufacturing of Specialty Pharmaceuticals and a wide range of Active Pharmaceutical Ingredients (API) has drawn up expansion plans for their existing manufacturing facility in Nanjangud KIADB industrial area, Mysuru.

This expansion assumes greater significance considering the call for Atmanirbhar Bharat program by Honourable Prime Minister of India Shri. Narendra Modi, given that 90% of India’s API requirement is imported from China. Hence, to be self-reliant in this very critical sector there is a renewed demand for APIs’ to be manufactured in India and cut the import dependence on China.  Considering the urgency, JGL had applied for Environmental clearance for their API expansion project on 27th July 2020 with the regulatory body- State Environment Impact Assessment Authority (SEIAA) – Karnataka.

The company cleared all statutory and regulatory requirements to obtain Environmental clearance (EC) from SEIAA – Karnataka on 5th September, 2020.

- Advertisement -

It is noteworthy to point out that JGL had undertaken a similar API expansion project in 2016-2017, raising their total annual capacity of products from 987 MTPA to the present 1395 MTPA. (Metric tons per annum)

Project brief

Jubilant Generics Ltd manufacturing facility produces a wide range of API (chemical compounds) for antidepressants, antimalarial, antifungal, antidiabetic, antihistamine, antimigraine to name a few of the many.  Biggest capacity addition is proposed for Gastrointestinal disorders, Antipsychotic, Antihypertensive, Antidiabetic class of medicines. Present capacity in MTPA of products and by products is 1395 and 5631, respectively. Post expansion, total capacity of products and by products shall be 1614 and 6348 MTPA, respectively.

The proposed expansion is planned within the existing land holding of Jubilant Generics Ltd, i.e. spread over 68.65 acres (277816.69 sqm), hence there is no demand for additional land to be acquired.

- Advertisement -

Expansion project entails construction of high tech material handling and storage tanks, electrical stations, installation of machinery, waste management and other allied facilities. Structures shall be of RCC and steel in nature.

JGL shall extend their solid waste management procedures for the expansion project as well, wherein, solid hazardous wastes having incinerable characteristics will be incinerated in the incinerator/co-processing, while the non incinerable inorganic wastes will be safely stored and disposed to treatment storage and disposal facilities (TSDF). Spent solvent recovery system will be in use to recover solvents which are reusable. For the liquid effluent management, the existing zero liquid discharge system will be augmented.  


The existing facility of JGL is located at Plot no. 18, 56, 57-58 & Plot no.1 of KIADB Nanjangud Industrial area. The facility is next to Nestle, off NH 766. Unit 1 which is currently operational is located on Plot no. 18, 56 , 57-58 and the proposed expansion in Unit 2 shall come up on Plot no.1 which is vacant and is south of Unit 1.

- Advertisement -


Direct employment- Expansion shall generate 1000 permanent & 400 contract jobs. Indirect employment shall be in logistics which involves movement of raw materials and APIs, which is expected to add about 500 jobs. JGL has given preference to local employment and the company emphasises to continue the trend. JGL has also undertaken various CSR initiatives in the region for community development.

Also Read: Three Tier Traffic Interchange at Columbia Asia Junction

- Advertisement -

Leave a Reply

- Advertisment -

Most Popular